5 Best Stocks to Buy for Deflation

02. AbbVie Inc. (NYSE:ABBV)

Number of Hedge Fund Holders as of Q3, 2022: 80

AbbVie Inc. (NYSE:ABBV) is an American biotech company that was formed after the spin-off of Abbott Laboratories in 2013. The company is one of the best stocks to buy for deflation. It has been raising its payouts consistently for the past 50 years. It currently pays a quarterly dividend of $1.48 per share and has a dividend yield of 3.63% as of December 27.

AbbVie Inc. (NYSE:ABBV) was a part of 80 hedge fund portfolios in Q3 2022, up from 71 in the previous quarter. The stakes owned by these hedge funds have a total value of over $1.86 billion. With over 3.2 million shares, Arrowstreet Capital was one of the company’s leading stakeholders in Q3.

Baron Funds mentioned AbbVie Inc. (NYSE:ABBV) in its Q3 2022 investor letter. Here is what the firm has to say:

“AbbVie Inc. (NYSE:ABBV) is a drug developer best known for Humira, an immunosuppressant that is the best selling drug of all time. Given outsized key product risk (patent cliff and generic launches beginning in 2023), AbbVie has broadened its pipeline, highlighted by its Allergan acquisition. Shares fell on results that missed consensus and indications that legacy franchises were outperforming newer product launches, calling into question AbbVie’s long-term strategy. With promising assets in the pipeline and its robust cash flow profile, we believe AbbVie will grow well into the future.”